SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Zollinger John J. IV

(Last)

(First)

(Middle)

503 KALISTE SALOOM ROAD

(Street)

LAFAYETTE

70508

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HOME BANCORP, INC. [ HBCP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SEVP, Chief Banking Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/25/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/25/2024		M		520	A	$22.25	6,029	D⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾⁽⁵⁾
Common Stock	10/25/2024		S		267	D	$45.825	5,762	D⁽¹⁾⁽²⁾⁽³⁾⁽⁴⁾⁽⁵⁾
Common Stock								1,287.6059	I	401K Plan
Common Stock								6,311.4072	I	ESOP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$28							⁽⁶⁾	05/23/2026	Common Stock	660		660	D
Employee Stock Option (Right to Buy)	$35.26							⁽⁷⁾	05/12/2027	Common Stock	750		750	D
Employee Stock Option (Right to Buy)	$45.12							⁽⁸⁾	05/23/2028	Common Stock	740		740	D
Employee Stock Option (Right to Buy)	$35.85							⁽⁹⁾	05/23/2029	Common Stock	850		850	D
Employee Stock Option (Right to Buy)	$21.99							⁽¹⁰⁾	03/12/2030	Common Stock	800		800	D
Employee Stock Option (Right to Buy)	$36.77							⁽¹¹⁾	05/12/2031	Common Stock	1,000		1,000	D
Employee Stock Option (Right to Buy)	$22.25	10/25/2024		M			520	⁽¹²⁾	05/12/2025	Common Stock	520	$0	0	D

Explanation of Responses:

1. Includes the grant of 1400 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2024, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 1,120 restricted stock units remain unvested.

2. Includes the grant of 1600 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2025, and that may be settled only in shares of the Issuer's common stock.

3. Includes the grant of 300 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on March 12, 2021, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 60 restricted stock units remain unvested.

4. Includes the grant of 425 restricted stock units pursuant to the Issuer's 2014 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2022, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 170 restricted stock units remain unvested.

5. Includes the grant of 975 restricted stock units pursuant to the Issuer's 2021 Incentive Plan that vest in equal installments at the rate of 20% per year commencing on May 12, 2023, and that may be settled only in shares of the Issuer's common stock. As of the date of this filing, 585 restricted stock units remain unvested.

6. The options vest and become exercisable in five equal installments beginning May 23, 2017. As of the date of this filing 660 options remain unexercised.

7. The options vest and become exercisable in five equal installments beginning May 12, 2018.

8. The options vest and become exercisable in five equal installments beginning May 23, 2019.

9. The options vest and become exercisable in five equal installments beginning May 23, 2020.

10. The options vest and become exercisable in five equal installments beginning March 12, 2021.

11. The options vest and become exercisable in five equal installments beginning May 12, 2022.

12. The options vest and become exercisable in five equal installments beginning May 12, 2016. As of July 15, 2024, 520 options remained unexercised.

	/s/ John J. Zollinger, IV	10/28/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.